Avalon Investment & Advisory Vivos Therapeutics, Inc. Transaction History

Avalon Investment & Advisory

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$1.63 - $3.63 $24,888 - $55,426	-15,269 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.11 $706,619 - $1.29 Million	-314,053 Reduced 95.36%	15,269 $34,000
Q3 2021 Nov 08, 2021	BUY	$2.71 - $5.9 $378,269 - $823,539	139,583 Added 73.57%	329,322 $1.33 Million
Q2 2021 Jul 29, 2021	BUY	$4.83 - $9.67 $98,169 - $196,542	20,325 Added 12.0%	189,739 $939,000
Q1 2021 May 13, 2021	BUY	$6.01 - $8.9 $1.02 Million - $1.51 Million	169,414 New	169,414 $1.13 Million

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.